Institution
Goldman Sachs Research Hub
Goldman Sachs research highlights 2026 as a pivotal growth year across multiple sectors, even as various regions navigate immediate macro headwinds. In the real estate and lodging space, the firm notes that CapitaLand Investment is executing an asset-light transition focused on divestments, while Airbnb is projected to achieve low-double-digit revenue growth driven by international expansion. Within the gaming sector, analysts remain optimistic about long-term catalysts like Wynn Resorts' UAE project, despite recent margin compression in Macau where GGR market share fell. Conversely, the firm has adopted a more cautious stance on Brazilian financials, downgrading BB Seguridade due to a cooling top-line and forecasted earnings contraction. Regarding China’s macro landscape, Goldman Sachs observes a divergence where total social financing beat expectations at RMB 7.22 trillion, yet primary property prices continued to fall by an annualized 5.3% in January. Overall, the research direction points toward tactical navigation of China's property correction while positioning for a recovery in global consumer and fee-based business models by 2026.
1529 reports available
All reports
Page 8 of 64
Europe Technology Hardware Update
Goldman Sachs · Jun 10, 2026
Global Healthcare Annual Global Healthcare Conference Notes From Investment Banker Panel
Goldman Sachs · Jun 10, 2026
European Financials Specialist Sales Update
Goldman Sachs · Jun 10, 2026
Flow and Positioning Observations
Goldman Sachs · Jun 10, 2026
TMT Specialist Sales Daily Wrap
Goldman Sachs · Jun 10, 2026
Japan Economic Flash: BOJ June MPM Review
Goldman Sachs · Jun 10, 2026
Russell 2k Rescued By Rotation
Goldman Sachs · Jun 10, 2026
Asia Pacific Textile Apparel and Footwear Monthly Tracker
Goldman Sachs · Jun 10, 2026
Americas Transportation Valuation Tracker
Goldman Sachs · Jun 10, 2026
Americas Entertainment Front Row Report Theater Industry And Box Office Tracker
Goldman Sachs · Jun 10, 2026
Global Equities Call
Goldman Sachs · Jun 10, 2026
Moderna Inc. Key Takeaways 47th Annual Global Healthcare Conference
Goldman Sachs · Jun 10, 2026
Ultragenyx Pharmaceutical Key Takeaways From 47th Annual Global Healthcare Conference
Goldman Sachs · Jun 10, 2026
Sana Biotechnology Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
New Amsterdam Pharma 47th Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
Flow of Funds Systematic Update
Goldman Sachs · Jun 10, 2026
Midday Market Intelligence
Goldman Sachs · Jun 10, 2026
Prospects for Euro Area Enlargement
Goldman Sachs · Jun 10, 2026
United Natural Foods Inc. (UNFI) Update
Goldman Sachs · Jun 10, 2026
Fed Communication And Rates Volatility
Goldman Sachs · Jun 10, 2026
Gilead Sciences Inc. (GILD): 47th Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
US Strategy Views Supply And Demand
Goldman Sachs · Jun 10, 2026
Americas Branded Consumer Goods Apparel and Accessories Monthly Brand Momentum Tracker Update
Goldman Sachs · Jun 10, 2026
China Healthcare Hospital Equipment Bidding Update
Goldman Sachs · Jun 10, 2026